SeraCare enables the promise of precision medicine by advancing the understanding of disease and providing assurance of the diagnostic result. Our innovative tools and technologies not only ensure the safe, effective, and accurate performance of diagnostic assays but also establish a framework for regulating, compiling, and interpreting data from precision diagnostics. Our portfolio includes a broad range of products such as quality control technologies, disease-state specimens and tissues for research and development, processed biological materials, and immunoassay reagents.
Join our mailing list @ http://bit.ly/19ZoZae
Join our mailing list @ http://bit.ly/19ZoZae
Location: United States, Massachusetts, Milford
Employees: 51-200
Phone: +1 508-244-6400
Founded date: 1984
Investors 1
| Date | Name | Website |
| 18.07.2021 | Linden Cap... | lindenllc.... |
Mentions in press and media 2
| Date | Title | Description |
| 13.02.2012 | SeraCare Announces Definitive Agreement to be Acquired by Linden Capital Partners | Shareholders to receive $4.00 per share in cash. Transaction valued at approximately $82 million. SeraCare Board of Directors Unanimous in its Recommendation. Conference Call Scheduled for 8:30 a.m. ET. |
| 13.02.2012 | Moody’s raises Boston Scientific rating again | Wall Street Beat | Shares of Boston Scientific (NYSE:BSX) are enjoying a modest gain today after Moody’s Investors Service (NYSE:MCO) upgraded its debt rating. The ratings agency said it believes BSX stock is less risky now that the Natick, Mass.-based medica... |